• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cara Therapeutics Inc

+ Add to Watchlist

69C:GR

6.258 EUR 0.054 0.87%

As of 11:05:52 ET on 10/24/2014.

Snapshot for Cara Therapeutics Inc (69C)

Open: 6.331 Day's Range: 6.258 - 6.373 Volume: 0
Previous Close: 6.204 52wk Range: 5.838 - 16.330 1-Yr Rtn: -

Stock Chart for 69C

No chart data available.
  • 69C:GR 6.258
  • 1D
  • 1M
  • 1Y
6.204
Interactive 69C Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 69C

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.8300
Est. PEG Ratio -
Market Cap (M EUR) 141.71
Shares Outstanding (M) 22.64
30 Day Average Volume 124
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/10/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 69C

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 69C

Cara Therapeutics, Inc. develops therapeutics. The Company offers novel drugs for the treatment of human diseases associated with pain and inflammation. Cara Therapeutics serves customers in the United States.

Derek ChalmersPresident/CEO/Co-FounderJosef C SchoellChief Financial Officer
Robert A MedveChief Medical OfficerFrederique MenzaghiVP:R&D/Co-Founder
More Company Profile & Key Executives for 69C

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil